Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by RoadKillDewmanon May 03, 2019 5:36pm
342 Views
Post# 29709226

Email response from Pierce.

Email response from Pierce. Good afternoon,
  I have quite a chunk of money invested in Aphria thinking it is a good play. That being said, there has been no mention as to what the 90 day plan is that Simon Irwin referred to. I’m wondering if there is any information regarding the 90 day plan?
 There has been no substantial news report since the day after earnings. The market seems to be focussed on oils a lot right now - how is the extraction facility coming along? Are there foreseen set backs coming up or are we on track to having it running in June/19 still? 
  Respectfully;

their response:

Hello Xxxxxxx

Thank you for interest and continued support in Aphria.
 
The 90-day strategic review is an internal analysis to focus and prioritize the deployment of resources on projects that provide the most immediate economic benefits and provide the largest contribution to shareholder value.
 
We strive to keep shareholders informed and up to date. If there are any material events such as investments, agreements, partnership, etc. we would publicly disclose it via press release as soon as possible.

The Extraction Centre of Excellence continues on schedule, which we anticipate being available for use by Q1 2020, subject to Health Canada approval.

* These statements constitute forward-looking information related to possible events, conditions or financial performance based on future economic conditions and courses of action. These statements involve known and unknown risks, assumptions, uncertainties and other factors that may cause actual results or events to differ materially. The Company believes there is a reasonable basis for the expectations reflected in the forward-looking statements, however, these expectations may not prove to be correct.  
 
Thanks, 
 
Joel Pierce
Investor Relations Administrator
Joel.Pierce@aphria.com
www.aphria.ca
Twitter | LinkedIn
 
Fkn knob. 
Bullboard Posts